Arko Scheepmaker

Effectiveness of an intervention to reduce sedentary behaviour as a personalised secondary prevention strategy for patients with coronary artery disease: main outcomes of the SIT LESS randomised clinical trial

Bram M. A. van Bakel, Sophie H. Kroesen, Esmée A. Bakker et al. · International Journal of Behavioral Nutrition and Physical Activity · 2023 · 49 citations · Full text

Medicine, Cardiology, Rehabilitation Medicine +17

Sedentary Behaviour Intervention as a Personalised Secondary Prevention Strategy (SIT LESS) for patients with coronary artery disease participating in cardiac rehabilitation: rationale and design of the SIT LESS randomised clinical trial

Bram M. A. van Bakel, Sophie H. Kroesen, A. Günal et al. · BMJ Open Sport & Exercise Medicine · 2022 · 32 citations · Full text

Medicine, Cardiology, Health Promotion +17

Should Acute Q-Fever Patients be Screened for Valvulopathy to Prevent Endocarditis?

M.M.A. de Lange, Laura E V Gijsen, Cornelia C. H. Wielders et al. · Clinical Infectious Diseases · 2018 · 13 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Relationship between In Vitro Lipopolysaccharide-Induced Cytokine Response in Whole Blood, Angiographic In-Stent Restenosis, and Toll-Like Receptor 4 Gene Polymorphisms

Saskia Z.H. Rittersma, Johanna A. Kremer Hovinga, Karel T. Koch et al. · Clinical Chemistry · 2005 · 12 citations · Full text

Life Sciences, Cardiology, Immunology +17

Risk of chronic Q fever in patients with cardiac valvulopathy, seven years after a large epidemic in the Netherlands

M.M.A. de Lange, Arko Scheepmaker, Wim van der Hoek et al. · PLoS ONE · 2019 · 11 citations · Full text

Medicine, Cardiology, Internal Medicine +14